SHILPA MEDICARE
|
The Current P/S Ratio of SHILPA MEDICARE is 4.64.
| Share Price | ₹339.7 | Feb 10,2026 |
| Market Cap | ₹6,643.6 Cr | |
| Sales-TTM | ₹1,432.0 Cr | TTM-Consolidated Results |
| Price/Sales | 4.64x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SHILPA MEDICARE
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹6,643.6 Cr] as on Feb 10,2026
(/) Sales [ ₹1,432.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.64x ]
Thus, for SHILPA MEDICARE , the investors are currently willing to pay '4.64 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SHILPA MEDICARE !
The chart below summarizes the trend in P/S Ratio of SHILPA MEDICARE over the last five years.
Historical PS (Price/Sales) ratio chart of SHILPA MEDICARE
PS Ratio Performance Analysis for SHILPA MEDICARE
- SHILPA MEDICARE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.29x.
- SHILPA MEDICARE 's operated at median p/e ratio of 3.02x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHILPA MEDICARE 's p/e ratio peaked in Mar2025 at 5.04x.
- SHILPA MEDICARE 's p/e ratio hit its five-year low in Mar2023 of 1.9x.
How does SHILPA MEDICARE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SHILPA MEDICARE | 1,432.0 | 4.64 | 6,643.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.21 | 409,698.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.34 | 163,866.0 |
| CIPLA LTD | 28,351.1 | 3.82 | 108,412.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.27 | 138,062.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.02 | 104,805.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.15 | 85,533.2 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.42 | 89,273.1 |
| LUPIN LTD | 24,750.7 | 4.07 | 100,736.0 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.00 | 65,186.3 |
| ABBOTT INDIA LTD | 6,714.4 | 8.64 | 58,041.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SHILPA MEDICARE 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.00x |
| Max industry PS | 16.34x |
| Median industry PS | 4.64x |
| Average industry PS | 6.42x |
You may also like the below Video Courses